[1. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.10.1161/01.CIR.100.19.1992]Search in Google Scholar
[2. Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement imaging. J Am Coll Cardiol. 2006; 47:1630-8.10.1016/j.jacc.2005.10.074]Search in Google Scholar
[3. Takase B, Nagata M, Kihara T, Kameyawa A, Noya K, Matsui T, et al. Whole-heart dipyridamole MRI for the detection of coronary artery disease stress first-pass myocardial perfusion. Jpn Heart J. 2004; 45:475-86.10.1536/jhj.45.475]Open DOISearch in Google Scholar
[4. Sakuma H, Suzawa N, Ichikawa Y, Makino K, Hirano T, Kitagawa K. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. Am J Roentgenol. 2005; 185:95-102.10.2214/ajr.185.1.01850095]Search in Google Scholar
[5. Cury RC, Cattani CA, Gabure LA, Racy DJ, de Gois JM, Siebert U, et al. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology. 2006; 240:39-45.10.1148/radiol.2401051161]Search in Google Scholar
[6. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson. 2008; 10:18.10.1186/1532-429X-10-18]Search in Google Scholar
[7. Tumkosit M, Puntawangkoon C, Morgan TM, Clark HP, Hamilton CA, Ntim WO, et al. Leftventricular infarct size assessed with 0.1 mmol/kg ofgadobenate dimeglumine correlates with that assessed with 0.2 mmol/kg of gadopentetate dimeglumine. J Comput Assist Tomogr. 2009; 33:328-33.10.1097/RCT.0b013e318187fed0]Search in Google Scholar
[8. Gibbons RJ, Balady GJ, Bricker JT. Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2002; 40:1531-40.10.1016/S0735-1097(02)02164-2]Search in Google Scholar
[9. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105:539-42.10.1161/hc0402.102975]Search in Google Scholar
[10. Schuijf JD, Poldermans D, Shaw LJ. Jukema JW, Lamb HJ, de Roos A, et al. Diagnostic and prognostic value of noninvasive imaging in known or suspected coronary artery disease. Eur J Nuc Med Mol Imaging. 2006; 33:93-104.10.1007/s00259-005-1965-y]Search in Google Scholar
[11. Lee VS, Resnick D, Tiu SS, Sanger JJ, Nazzaro CA, Israel GM, et al. MR imaging evaluation of myocardial viability in the setting of equivocal SPECT results with 99mTc sestamibi. Radiology. 2004; 230:191-7.10.1148/radiol.2301030070]Search in Google Scholar
[12. Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischemic cascade. Heart. 2009; 95:49-55.10.1136/hrt.2007.139683]Search in Google Scholar
[13. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular resonance imaging. N Engl J Med. 2002; 346:1948-53.10.1056/NEJMoa012369]Search in Google Scholar
[14. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast enhancedmagnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343:1445-3.10.1056/NEJM200011163432003]Search in Google Scholar
[15. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Magnetic resonance perfusion measurement for the noninvasive detection of coronary artery disease. Circulation. 2003; 108:432-7.10.1161/01.CIR.0000080915.35024.A9]Search in Google Scholar
[16. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz- MengerJ, Messroghli MG, Friedrich MG. Detection of acutely impaired microvascular reperfusion after infarctangioplasty with magnetic resonance imaging. Circulation. 2004; 109:2080-5.10.1161/01.CIR.0000127812.62277.50]Search in Google Scholar